Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Does Estimated Pulse Wave Velocity Add Prognostic Information? MORGAM Prospective Cohort Project

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Level of Physical Activity, Left Ventricular Mass, Hypertension, and Prognosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Dose-Response Association Between Level of Physical Activity and Mortality in Normal, Elevated, and High Blood Pressure

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Abdominal Adiposity Distribution Quantified by Ultrasound Imaging and Incident Hypertension in a General Population

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Prognosis in relation to blood pressure variability: con side of the argument

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Cardiac Troponin I and Incident Stroke in European Cohorts: Insights From the BiomarCaRE Project

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Association between antecedent blood pressure, hypertension-mediated organ damage and cardiovascular outcome

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function

    Research output: Contribution to journalJournal articleResearchpeer-review

  • MORGAM Project*
View graph of relations

The Reference Values for Arterial Stiffness Collaboration has derived an equation using age and mean blood pressure to estimated pulse wave velocity (ePWV), which predicted cardiovascular events independently of Systematic COoronary Risk Evaluation (SCORE) and Framingham Risk Score. The study aim was to investigate the independent association between ePWV and clinical outcomes in 107 599 apparently healthy subjects (53% men) aged 19 to 97 years from the MORGAM Project who were included between 1982 and 2002 in 38 cohorts from 11 countries. Using multiple Cox-regression analyses, the predictive value of ePWV was calculated adjusting for country of inclusion and either SCORE, Framingham Risk Score, or traditional cardiovascular risk factors (age, sex, smoking, systolic blood pressure, body mass index [BMI], total and high-density lipoprotein cholesterol). Cardiovascular mortality consisted of fatal stroke, fatal myocardial infarction, or coronary death, and the composite cardiovascular end point consisted of stroke, myocardial infarction, or coronary death. Model discrimination was assessed using Harrell's C-statistic. Adjusting for country and logSCORE or Framingham Risk Score, ePWV was associated with all-cause mortality (hazard ratio, 1.23 [95% CI 1.20-1.25] per m/s or 1.32 [1.29-1.34]), cardiovascular mortality (1.26 [1.21-1.32] or 1.35 [1.31-1.40]), and composite cardiovascular end point (1.19 [1.16-1.22] or 1.23 [1.20-1.25]; all P<0.001). However, after adjusting for traditional cardiovascular risk factors, ePWV was only associated with all-cause mortality (1.15 [1.08-1.22], P<0.001) and not with cardiovascular mortality (0.97 [0.91-1.03]) nor composite cardiovascular end point (1.10 [0.97-1.26]). The areas under the last 3 receiver operator characteristic curves remained unchanged when adding ePWV. Elevated ePWV was associated with subsequent mortality and cardiovascular morbidity independently of systematic coronary risk evaluation and Framingham Risk Score but not independently of traditional cardiovascular risk factors.

Original languageEnglish
JournalHypertension
Volume75
Issue number6
Pages (from-to)1420-1428
Number of pages9
ISSN0194-911X
DOIs
Publication statusPublished - Jun 2020

    Research areas

  • cardiovascular risk, prognosis, pulse wave velocity, reclassification

ID: 59691067